- » Focus and Scope
- » Section Policies
- » Peer Review Process
- » Publication Frequency
- » Open Access Policy
Focus and Scope
Aim and Scope Journal of Tumor (ISSN 1819-6187) is a bimonthly, open accessed, peer reviewed journal. The journal welcomes original significant and up-to-date articles on all aspects of experimental and clinical oncology. Scope of the journal covers: JT publishes original research, reviews and other material related to breast cancer, gastrointestinal cancer, hematologic malignancies, molecular oncology, lung cancer, genitourinary cancer, head and neck cancer, pediatric oncology, neurooncology, supportive care and quality of life issues, prevention, and phase I and clinical pharmacology. The journal publishes research papers in areas of research include, but are not limited to, the following: Clinical diagnosis, laboratory diagnosis, differential diagnosis, imaging tests, pathological diagnosis, molecular biological diagnosis, immunological diagnosis, genetic diagnosis, functional diagnostics, and physical diagnosis; and comprehensive therapy, drug therapy, surgical therapy, interventional treatment, minimally invasive therapy, and robot-assisted therapy.
Section Policies
Editorial
Open Submissions | Indexed | Peer Reviewed |
Topic Highlight
Open Submissions | Indexed | Peer Reviewed |
Review
Open Submissions | Indexed | Peer Reviewed |
Original Article
Open Submissions | Indexed | Peer Reviewed |
Articles
Open Submissions | Indexed | Peer Reviewed |
Case Report
Open Submissions | Indexed | Peer Reviewed |
Letters to the Editor
Open Submissions | Indexed | Peer Reviewed |
Peer Review Process
Submitted manuscripts will be sent to peer reviewers, unless they are either out of scope or below threshold for the journal, or the presentation or written English is of an unacceptably low standard. Editors send four reviewers the request to review with the submission attached to the email. Reviewers email editors their assent (or regrets), as well as the review and recommendation. In order to facilitate the editing process and to improve the efficiency of JGHR, all peer reviewers are requested to return their comments within two weeks. All reviewers must keep the manuscripts confidential. They must not give the manuscript to any third party, or discuss the contents of the articles with the authors of the manuscript or other persons. If the reviewers feel that there is an interest conflict with the authors, personally, academically or economically, then the reviewer must inform the Editorial Office immediately.
Publication Frequency
This journal is published 6 times per year.
Open Access Policy
The Journal of Tumor adopt the OA publishing model allows us to reach all readers by eliminating cost barriers and other challenges related to physical delivery. We continually strive to improve our users experience in the digital environment, and our efforts include:
• Providing articles in multiple formats, including HTML, PDF.
• An OA compendium of full-text articles provided to readers for free;
• Building transparency by providing open access to the Peer-Review Reports and Authors’ Responses for each published article;
• Constructing sustainable digital preservation archives with open access.
ISSN: 1819-6187